Fundz

New Equilibrium Biosciences, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEApr 25, 2022

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Apr 25, 2022)

Round Type

Venture

CambridgeBiotechnology

Quick answer

New Equilibrium Biosciences, Inc. raised $10 Million in a funding round, dated April 25, 2022. New Equilibrium Biosciences, Inc. is based in Cambridge, Maryland, United States.

How much did New Equilibrium Biosciences, Inc. raise?
New Equilibrium Biosciences, Inc. raised $10 Million in a funding round on April 25, 2022.
What does New Equilibrium Biosciences, Inc. do?
Virginia Burger, Ph.D. and Peter Tompa, Ph.D. founded New Equilibrium in 2019 to discover new medicines for patients with life-threatening diseases.
Where is New Equilibrium Biosciences, Inc. based and how big is it?
New Equilibrium Biosciences, Inc. is based in Cambridge, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as New Equilibrium Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Ana Bios raised $6.5M on June 9, 2022.
  • Heligenics raised $2.2M (Seed) on June 9, 2022.
  • Corvia Medical raised $54M (Funding Round) on June 9, 2022.
  • Revalesio raised $12M on June 9, 2022.
  • Bio-AI Health Inc. raised $3M (Seed) on June 8, 2022.
  • Centrexion Therapeutics raised $16M on June 8, 2022.

Who to call at New Equilibrium Biosciences, Inc., and when

A new round usually means New Equilibrium Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day New Equilibrium Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at New Equilibrium Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at New Equilibrium Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

New Equilibrium Biosciences, Inc.

Location

700 Main Street

Cambridge, Maryland, United States

About

Virginia Burger, Ph.D. and Peter Tompa, Ph.D. founded New Equilibrium in 2019 to discover new medicines for patients with life-threatening diseases. NEQ's platform marries AI and biophysics to reveal experimentally-invisible conformations of shapeshifting proteins. This first-in-kind technology enables the rational design of drugs targeting the elusive class of intrinsically disordered proteins, including many of the most desirable targets for cancer, neurodegeneration, and other indications. Supported by a world-class Scientific Advisory Board, New Equilibrium has attracted grant and venture funding to build a cross-disciplinary team of experts in AI, biophysics, and quantum chemistry. To learn more, please visit www.newequilibriumbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment New Equilibrium Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for New Equilibrium Biosciences, Inc.'s next move

See what Strategic adds

New Equilibrium Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.